Clinical Trials Directory

Trials / Conditions / Loss of Chromosome 17p

Loss of Chromosome 17p

8 registered clinical trials studyying Loss of Chromosome 17p.

StatusTrialSponsorPhase
TerminatedIrradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malig
NCT03272633
Rutgers, The State University of New JerseyEARLY_Phase 1
WithdrawnIbrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
NCT03943342
Kerry RogersPhase 2
Unknowna Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients
NCT04008888
Institute of Hematology & Blood Diseases Hospital, ChinaN/A
CompletedIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
NCT02633059
Mayo ClinicPhase 1 / Phase 2
CompletedNivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphoc
NCT02420912
M.D. Anderson Cancer CenterPhase 2
CompletedDonor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell
NCT01527045
Fred Hutchinson Cancer CenterPhase 2
CompletedBortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Don
NCT01163357
City of Hope Medical CenterPhase 1
CompletedAutologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients
NCT01008462
Fred Hutchinson Cancer CenterPhase 2